Elsevier

Neuroscience

Volume 230, 29 January 2013, Pages 24-30
Neuroscience

d-Cycloserine administered directly to infralimbic medial prefrontal cortex enhances extinction memory in sucrose-seeking animals

https://doi.org/10.1016/j.neuroscience.2012.11.004Get rights and content

Abstract

d-Cycloserine (DCS), a co-agonist at the N-methyl-D-aspartate (NMDA) receptor, has proven to be an effective adjunct to cognitive behavioral therapies that utilize extinction. This pharmacological-based enhancement of extinction memory has been primarily demonstrated in neuropsychiatric disorders characterized by pathological fear (e.g. posttraumatic stress disorder and various phobias). More recently, there has been an interest in applying such a strategy in the disorders of appetitive learning (e.g. substance abuse and other addictions), but these studies have generated mixed results. Here we first examined whether extinction memory encoding in a sucrose self-administration model is dependent on NMDA receptors. The NMDA antagonist (±)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid (5 mg/kg, i.p.) administered 2 h prior to the first extinction training session effectively inhibited extinction memory recall 24 h later, without affecting the expression of the conditioned sucrose-seeking response while the drug was on board. This profile of effects suggests a specific effect on extinction memory consolidation. Next, we sought to enhance extinction memory using the co-agonist DCS (10 μg/side) by infusion directly into infralimbic medial prefrontal cortex, a brain site implicated in extinction memory recall in conditioned fear models. Indeed, infusion of DCS immediately after the first extinction training session effectively enhanced extinction memory recall 24 h later. Collectively, these data suggest that the neurobiological mechanisms and the neurocircuitry mediating extinction memory are similar regardless of the valence (aversive or appetitive) of the conditioned behavior, and that similar pharmacological strategies for treatment may be applied to neuropsychiatric disorders characterized by a failure to inhibit pathological emotional memories.

Highlights

► NMDA-receptor activation is necessary for the extinction of sucrose seeking. ► DCS enhances the extinction of sucrose seeking animals via direct action in the infralimbic cortex. ► Bidirectional modulation of NMDA receptors impaired and enhanced extinction memory.

Introduction

Extinction training can be used to develop and strengthen the inhibition of undesirable conditioned responses. This type of training involves exposure to various cues that trigger the conditioned response, but in the absence of the unconditioned stimulus that was originally paired with those cues. With repeated cue exposure, the conditioned response is suppressed, owing to this new inhibitory extinction memory (Quirk et al., 2006). Pharmacological adjuncts can be administered before or after the training session to enhance extinction memory consolidation and promote the effects of behavioral therapy. For example, the N-methyl-D-aspartate (NMDA) receptor partial agonist, d-cycloserine (DCS), has been used effectively for this purpose in the extinction of pathological fear, and in some cases, the extinction of drug-associated cues in addicts (Santa Ana et al., 2009, Choi et al., 2010). In general, however, there are relatively few reports on the efficacy of DCS as an extinction memory enhancer in appetitive learning paradigms. This raises the question of whether the same pharmacological strategies can be applied to extinction therapy in different patient populations.

Preclinical animal models have been incredibly helpful in delineating the neurobiological mechanisms and neurocircuitry of extinction memory. Much of this work has been done in Pavlovian-conditioned fear models, where extinction memory has been shown to rely on NMDA receptors (Baker and Azorlosa, 1996, Lee et al., 2006, Burgos-Robles et al., 2007). Specifically, NMDA receptor-mediated bursting in infralimbic medial prefrontal neurons is critical for extinction memory consolidation (Burgos-Robles et al., 2007). Consistent with this, infralimbic lesions performed prior to Pavlovian fear conditioning do not disrupt the expression of fear during conditioning, nor do they disrupt the short-term memory for extinction, but long-term extinction memory is specifically impaired (Morgan et al., 1993). Hence, the infralimbic cortex is especially important for the consolidation of extinction memory. That infralimbic neuronal bursting and extinction memory formation can be disrupted with NMDA antagonists indicates an endogenous requirement of these receptors, but does little in the way of therapy. Stimulating NMDA receptors directly is problematic owing to their susceptibility to induce seizure (Ghasemi and Schachter, 2011). The co-agonist DCS provides an ideal mechanism for enhancing NMDA-receptor function, in that it facilitates channel opening in response to endogenous glutamate (Pitkanen et al., 1994, Dravid et al., 2010).

Recently, infusion of DCS directly into the infralimbic cortex effectively enhanced extinction memory in a Pavlovian-conditioned fear model (Chang and Maren, 2011). To our knowledge, this was the first demonstration of an infralimbic site of action for the extinction-memory enhancing effects of DCS. While there are a few mixed reports on the effects of systemic DCS on the extinction of operant appetitive memories (Vengeliene et al., 2008, Shaw et al., 2009, Vurbic et al., 2011), no studies have yet addressed the role of infralimbic NMDA receptors in the extinction of operant responding for rewards. A lesion study by Rhodes and Killcross (2004) suggests that the infralimbic cortex may play a similar role in suppressing conditioned food-seeking responses as it does for conditioned fear, suggesting that these mechanisms may generalize across reward and punishment. We first set out to verify that extinction memory in sucrose-seeking rats depends on endogenous NMDA receptors under the parameters used in our self-administration model. Thereafter we sought to enhance extinction memory by the direct infusion of DCS into the infralimbic cortex.

Section snippets

Subjects

Male, Wistar rats (Harlan; Sulzfeld, German) weighing approximately 280–300 g at the start of the experiment were housed in a temperature- and humidity-controlled vivarium on a 12 h reverse light–dark cycle (7.00 am lights off). Food and water were available ad libitum throughout the experiment. Behavioral sessions were conducted during the dark phase, at the same time of the day each day. The study was approved by the Animal Care committee at the VU University of Amsterdam.

Drugs and microinfusions

Both

CPP disrupts extinction memory formation in sucrose-seeking animals

Rats were trained to self-administer sucrose over a period of 3 weeks and were then assigned to saline (SAL) and CPP treatment groups (n = 10/group) based on their average responding over the last three FR4 sessions. These groups were not statistically different in the number of total active (532 ± 32 SAL, 514 ± 23 CPP) or inactive (6 ± 1 SAL, 4 ± 1 CPP) responses (p-values > 0.1). Twenty-two hours after the last sucrose self-administration session, rats were injected with SAL or CPP (5 mg/kg, i.p.) and 2h

Discussion

Here we investigated the role of NMDA receptors, particularly within the infralimbic medial prefrontal cortex, in extinction memory formation in a sucrose-seeking self-administration model. The NMDA-receptor antagonist CPP administered prior to the first extinction training session disrupted extinction memory recall on a long-term memory test 24 h later, without disrupting performance during training. This profile suggests that NMDA receptors do not mediate the expression of the conditioned

References (47)

  • M.A. Morgan et al.

    Extinction of emotional learning: contribution of medial prefrontal cortex

    Neurosci Lett

    (1993)
  • M. Pitkanen et al.

    d-Cycloserine, a partial agonist at the glycine site, enhances the excitability of dentate granule cells in vivo in rats

    Eur J Pharmacol

    (1994)
  • G.J. Quirk et al.

    Prefrontal mechanisms in extinction of conditioned fear

    Biol Psychiatry

    (2006)
  • E.J. Santa Ana et al.

    d-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: a pilot investigation

    Drug Alcohol Depend

    (2009)
  • P.K. Thanos et al.

    d-Cycloserine accelerates the extinction of cocaine-induced conditioned place preference in C57bL/c mice

    Behav Brain Res

    (2009)
  • N. Abumaria et al.

    Effects of elevation of brain magnesium on fear conditioning, fear extinction, and synaptic plasticity in the infralimbic prefrontal cortex and lateral amygdala

    J Neurosci

    (2011)
  • O. Albayrak et al.

    Does food addiction exist? A phenomenological discussion based on the psychiatric classification of substance-related disorders and addiction

    Obes Facts

    (2012)
  • J.D. Baker et al.

    The NMDA antagonist MK-801 blocks the extinction of Pavlovian fear conditioning

    Behav Neurosci

    (1996)
  • C.H. Chang et al.

    Medial prefrontal cortex activation facilitates re-extinction of fear in rats

    Learn Mem

    (2011)
  • D.C. Choi et al.

    Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder

    Curr Top Behav Neurosci

    (2010)
  • C.A. Conklin et al.

    Applying extinction research and theory to cue-exposure addiction treatments

    Addiction

    (2002)
  • J.W. de Jong et al.

    Towards an animal model of food addiction

    Obes Facts

    (2012)
  • S.M. Dravid et al.

    Structural determinants of d-cycloserine efficacy at the NR1/NR2C NMDA receptors

    J Neurosci

    (2010)
  • Cited by (0)

    Tel: +31-20-444-8101; fax +31-20-444-8100.

    View full text